Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mesoblast Ltd.
DescriptionAllogeneic cell therapy of mesenchymal precursor cells (MPCs) derived from adult bone marrow cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard IndicationBone repair
Indication DetailsPromote posterior lumbar and cervical interbody spinal fusion
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today